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Summary
Most Apicomplexa are obligatory intracellular
parasites that multiply inside a so-called parasito-
phorous vacuole (PV) formed upon parasite entry
into the host cell. Plasmodium, the agent of malaria
and the Apicomplexa most deadly to humans, mul-
tiplies in both hepatocytes and erythrocytes in the
mammalian host. Although much has been learned
on how Apicomplexa parasites invade host cells
inside a PV, little is known of how they rupture
the PV membrane and egress host cells. Here, we
characterize a Plasmodium protein, called LISP1
(liver-speciﬁc protein 1), which is speciﬁcally
involved in parasite egress from hepatocytes.
LISP1 is expressed late during parasite develop-
ment inside hepatocytes and locates at the PV
membrane. Intracellular parasites deﬁcient in
LISP1 develop into hepatic merozoites, which dis-
play normal infectivity to erythrocytes. However,
LISP1-deﬁcient liver-stage parasites do not rupture
the membrane of the PV and remain trapped inside
hepatocytes. LISP1 is the ﬁrst Plasmodium protein
shown by gene targeting to be involved in the lysis
of the PV membrane.
Introduction
Plasmodium, the agent of malaria, is an Apicomplexan
parasite that cycles through a mosquito and a mammalian
host. In the mammalian host, it multiplies by schizogony
inside hepatocytes and erythrocytes. The parasite form
inoculated by the mosquito, the sporozoite, invades hepa-
tocytes where it transforms into thousands of merozoites,
which in turn invade erythrocytes. The successive cycles
of merozoite multiplication inside erythrocytes then cause
the disease pathology (Miller et al., 2002a,b).
The two cell invasive stages of Plasmodium, the sporo-
zoite and the merozoite, differentiate intracellularly within
a parasitophorous vacuole (PV). The PV membrane
(PVM), which is formed upon zoite entry and is mainly
derived from the host cell plasma membrane, is devoid of
host cell integral proteins and thus prevents PV fusion to
endosomal compartments (Lingelbach and Joiner, 1998;
Bano et al., 2007). The PVM thus provides a safe niche
for the maturing parasite and allows passage of vital nutri-
ents and signals via channels and transporters (see
review Charpian and Przyborski, 2008). Among the para-
site proteins known to be present in the PVM of infected
erythrocytes are exported protein 1 (EXP1) (Simmons
et al., 1987) and several members of the early transcribed
membrane proteins (ETRAMP) family, which are integral
PVM proteins organized in oligomeric arrays (Spielmann
et al., 2006). In hepatocytes, the PVM also contains EXP1
(Doolan et al., 1996) and the stage-speciﬁc ETRAMPs
known as UIS3 and UIS4 (Matuschewski et al., 2002).
The latter two proteins are expressed in sporozoites and
early liver stages (LS) and are essential for their growth
(Mueller et al., 2005a,b; Tarun et al., 2007).
Once the parasite has multiplied inside the PV, how the
progeny exits the PV and the host cell remains largely
unknown (Blackman, 2008). Electron (Aikawa, 1971) and
live (Wickham et al., 2003) microscopy have provided
evidence for two distinct stages in the release of merozoi-
tes from erythrocytes, with the successive rupture of the
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cellular microbiologyPVM and of the erythrocyte membrane. The two-step
model applies to the release of merozoites from hepato-
cytes (Meis and Verhave, 1988; Sturm et al., 2006; 2009).
After disruption of the PVM, merozoite-ﬁlled membrane-
bound extrusions, called merosomes (Sturm et al., 2006;
2009; Baer et al., 2007; Thiberge et al., 2007), detach
from the infected hepatocyte before releasing free mero-
zoites into the blood circulation.
Here, we identify and characterize a Plasmodium
protein, called LISP1 (liver-speciﬁc protein 1), which is
speciﬁcally expressed by the LS and is expressed at high
levels late during its development. Inactivation of Lisp1 in
Plasmodium berghei indicates that LISP1 is important for
the destruction of the PVM surrounding the LS.
Results
Identiﬁcation of Lisp1
We previously constructed expressed sequence tag
(EST) libraries from various stages of P. berghei ANKA
parasites, including ookinetes, midgut sporozoites, sali-
vary gland sporozoites, LS isolated from a rat liver 31 h
post infection with sporozoites, and merozoites. Lisp1
was identiﬁed as a transcript present only in the LS library
and it aligned to four annotated P. berghei genes:
PB000708.00.0, PB001247.00.0, PB000682.00.0 and
PB000250.00.0. An independent in silico analysis also
selected PB000708.00.0 and PB000682.00.0 as candi-
date liver-speciﬁc genes and real-time PCR analysis con-
ﬁrmed that they were highly expressed in LS. The Lisp1
transcript is predicted to encode a protein of 3249 amino
acids (Accession No. AB231328) with a signal peptide
sequence and a potential EF-hand but no other recogniz-
able functional domain (http://www.plasmodb.org). The
Plasmodium yoelii Lisp1 orthologue (PY04499) has
recently been detected in a proteomic analysis of in-
fected hepatocytes (Tarun et al., 2008). Orthologues of
P. berghei Lisp1 are also found in Plasmodium falciparum
(PF14_0179) and Plasmodium vivax (PVX_085550), but
not in other Apicomplexa parasites such as Cryptospo-
ridium hominis, Toxoplasma gondii, Theileria annulata or
Eimeria tenella.
Lisp1 is expressed speciﬁcally in LS
To conﬁrm the LS-speciﬁc expression of Lisp1, real-time
PCR analysis was performed on RNA isolated from NK65
blood stages and salivary gland sporozoites, as well as
infected HepG2 cells at different time points (Fig. 1A).
Lisp1 messenger RNA (mRNA) was barely detectable in
blood stages, present at low levels in sporozoites, and its
quantity increased dramatically during parasite develop-
ment in HepG2 cells with a peak at 40 h (104-fold increase
compared with blood stages). Similar results were
obtained with RNA isolated from the liver of rats infected
with P. berghei ANKA, with Lisp1 expression peaking at
48 h (Fig. S1). Thus Lisp1 appeared to be most highly
expressed at late stages of intrahepatocytic parasite
development, when merozoites are formed.
Next, the subcellular localization of LISP1 was
addressed by immunoﬂuorescence analysis (IFA) with an
anti-LISP1 polyclonal antibody. While no signal was
detected in midgut or salivary gland sporozoites (not
shown) or puriﬁed blood-stage schizonts, parasites devel-
oping in the liver of rat 48 h after sporozoite inoculation
were brightly stained (Fig. 1B). LISP1 was also detected in
infected HepG2 cells at 36, 48 and 65 h post infection
(Fig. 1C) where it appeared to be associated with the PVM
surrounding the developing LS. To better deﬁne the local-
ization of LISP1, IFA was performed with anti-LISP1 and
anti-EXP1 antibodies. As shown in Fig. 1D, the two pro-
teins colocalized conﬁrming that LISP1 is present in the
PVM and in agreement with the localization of PY04499 in
P. yoelii-infected hepatocytes (Tarun et al., 2008).
LISP1-deﬁcient parasites have a decreased infectivity
to the mammalian host
To address the in vivo function of LISP1, we inactivated
the gene in both wild-type (WT) ANKA and NK65 strains
of P. berghei by double-cross-over recombination. The
endogenous Lisp1 was either interrupted by the select-
able marker (Lisp1I) (Fig. 2A) or replaced by the marker
(Lisp1D) (Fig. 2B). The Lisp1I modiﬁcation was introduced
in the WT ANKA strain, generating clone Lisp1I. The
Lisp1D modiﬁcation was introduced in WT NK65, gener-
ating the clone NK65Lisp1D, and in an ANKA strain
expressing green ﬂuorescent protein (GFP) (Janse et al.,
2006a), generating clone Lisp1DGreen. Southern blot
analysis conﬁrmed the expected structure of all recombi-
nant loci (Fig. S2). The absence of LISP1 protein in
Lisp1DGreen parasites was conﬁrmed by IFA of infected
HepG2 cells with an anti-LISP1 antibody (Fig. 2C). Using
the same antibody, Western blot analysis of extracts from
HepG2 cells 48 h post infection with WT ANKA sporozoi-
tes detected the expected 380 kDa band, whereas no
band was observed upon infection with Lisp1D parasites
(Fig. 2D).
All the Lisp1 mutant parasite clones displayed similar
growth rates in mouse blood stages and similar infectivity
in mosquitoes, and yielded similar numbers of salivary
gland sporozoites when compared with WT parasites (not
shown). This indicated that Lisp1 has no essential role in
erythrocytic and mosquito stages. The infectivity of mutant
sporozoites was measured by checking the emergence of
blood-stage parasites in rats injected intravenously with
Lisp1I salivary gland sporozoites. The parasitaemias
1330 T. Ishino et al.
© 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1329–1339obtained with mutant sporozoites were signiﬁcantly differ-
ent (P = 1.4 ¥ 10-7) from those obtained with WT sporo-
zoites (Fig. 2E) and indicated a 15-fold decrease in
infectivity. Similar results were obtained with all Lisp1
mutants (Fig. S3), so the two ANKA-derived mutants,
Lisp1I and Lisp1DGreen, were used for further analysis.
Mutant LS parasites are impaired in merozoite release
We then examined the intrahepatocytic development of
mutant parasites. First, 300 000 ANKA or Lisp1I sporozoi-
tes were injected intravenously into rats and 48 h later the
number of LS were counted in liver sections immuno-
stained with anti-CS antibodies. No signiﬁcant difference
was observed between the numbers of ANKA and Lisp1I
LS parasites (Fig. 3A). Second, the development of WT
and Lisp1DGreen LS was assessed with an anti-UIS4
antibody. The presence of a PVM was detected until 48 h
in both WT and mutant parasites (Fig. 3B). Furthermore,
when WT and Lisp1I (or Lisp1DGreen) sporozoites were
incubated with HepG2 cells there was no signiﬁcant dif-
ference in the number of LS parasites at 48 or 64 h (data
not shown). Finally, we assessed by real-time imaging the
development of WT and mutant LS at 24, 36 and 48 h post
infection of HepG2 cells. Again there was no signiﬁcant
difference in the size of WT compared with mutant LS
over this period (Fig. S4).
To examine hepatic merozoite development, the
numbers of merozoites released from HepG2 cells 65 h
post infection were compared between the WT and
mutant parasites. To internally control experiments, mixed
infections were performed with a 1:1 ratio of sporozoites
of Lisp1DGreen and of WTRed, a WT ANKA derivative
that expresses red ﬂuorescent protein (RFP) from the
Fig. 1. Pblisp1 is speciﬁcally expressed in late liver stages and localizes to the PVM.
A. Histogram representation of real-time RT-PCR analysis of lisp1 relative gene expression in P. berghei sporozoites (SPZ), HepG2 cells 5,
17, 40 and 50 h post infection and mixed blood stages (BS). The value was normalized to the expression of hsp70 mRNA in each sample.
Error bars are standard deviation.
B. Immunoﬂuorescence analysis of frozen sections of rat liver 48 h post infection (LS) and puriﬁed BS schizonts. Samples were incubated with
an anti-LISP1 antibody followed by FITC-conjugated secondary antibody and nuclei were stained with DAPI (scale bar 5 mm).
C. Micrograph of confocal section of LS. HepG2 cells were ﬁxed at 24, 36, 48 and 65 h post infection with WT ANKA sporozoites, incubated
with an anti-LISP1 antibody followed by Alexa 488-conjugated secondary antibody and nuclei stained with DAPI (scale bars 20 mm).
D. Micrograph of confocal section of LS. HepG2 cells were ﬁxed 48 h post infection with WT ANKA sporozoites, incubated with anti-LISP1 and
anti-EXP1 antibodies followed by Alexa 488-conjugated secondary antibodies and nuclei stained with DAPI (scale bar 20 mm).
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versus red merozoites (G/R) released in the culture super-
natant was calculated (see Table 1). To verify that green
and red merozoites were detected with similar efficiency,
cells were co-infected with a 1:1 ratio of WTGreen and
WTRed sporozoites. An average G/R merozoite ratio of 1
was found, conﬁrming that green- and red-ﬂuorescent
merozoites were detected with similar efficiency. In con-
trast, co-infections with Lisp1DGreen and WTRed para-
sites gave an average G/R merozoite ratio of 0.1:1. The
10-fold reduction in the number of merozoites released by
mutant LS suggested that LISP1 might be important
for merozoite formation within, or escape from infected
hepatocytes.
To evaluate the number of hepatic merozoites formed in
lisp1 mutant LS, adherent HepG2 cells, co-infected with
Lisp1DGreen and WTRed sporozoites, were recovered
after 65 h and mechanically disrupted to release the mero-
zoites. The ratio of Lisp1DGreen to WTRed merozoites
was~1(Fig. 4,leftpanelcells,hMZ),indicatingthatmutant
parasites generated normal numbers of merozoites. Next,
the infectivity of mutant merozoites was tested. When the
approximately 1:1 ratio of Lisp1DGreen to WTRed mero-
zoites collected from the disrupted HepG2 cells was
injected into mice, the same ratio was found in the ensuing
blood stages (Fig. 4, left panel cells, iRBC). Further, when
supernatants from the mixed infections collected at
65 h were injected intravenously into mice, the ratio of
Lisp1DGreen : WTRedblood-stageparasites(Fig. 4,right,
supernatant) was the same as the ratio of injected hepatic
merozoitesandwasmaintainedafterseveralmultiplication
cycles, showing that the merozoites released from lisp1
mutant LS were indeed infectious (see also Fig. S5) and
had similar infectivity to red blood cells compared with WT.
Fig. 2. Targeted gene disruption of lisp1.
A. Schematic representation of Lisp1I gene disruption.
B. Schema of Lisp1D gene disruption. Shaded boxes indicate the regions of homology used for double-cross-over recombination; black boxes
indicate the selectable marker; Met and the asterisk (*) indicate the initiation and stop codons respectively.
C. Absence of LISP1 protein in Lisp1D parasites. Microscopy image of HepG2 cells 48 h post infection with WTGreen or Lisp1DGreen. LS
were labelled with anti-LISP1 antibody and Alexa 647-conjugated secondary antibody (red); nuclei stained with DAPI (blue).
D. Western blot analysis of extracts of HepG2 cells 48 h post infection with ANKA (WT) or Lisp1DGreen sporozoites. Arrowheads indicate the
bands of LISP1 and human GAPDH.
E. Lisp1I sporozoites have a decreased infectivity in the mammalian host. A total of 30 000 wild-type or Lisp1I sporozoites, from two
independent Lisp1I clones, were injected intravenously into rats and blood parasitaemias were examined by Geimsa staining. The error bars
show the standard errors from three rats.
Fig. 3. Lisp1-defective parasites develop
normally, within a PVM, into late-stage LS.
A. Histogram representation of the number of
LS in vivo. A total of 300 000 wild-type or
Lisp1I sporozoites were injected intravenously
into rats and 48 h later the number of WT
(white box) and Lisp1I (black box) LS were
counted in the liver sections. Bars indicate the
standard deviation from three rats.
B. Confocal micrograph of PVM in
Lisp1-defective parasites. HepG2 cells 36 and
48 h post infection with WT (Wild type) or
Lisp1DGreen sporozoites. LS parasites
(green) labelled with an anti-UIS4 antibody
(red) and nuclei stained with DAPI (blue).
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of LISP1 infectious merozoites are formed normally but
are not released efficiently from the LS.
Mutant LS do not rupture the PVM
We next examined the morphology of late stages of LS
development by transmission electron microscopy (TEM).
HepG2 cells were infected with WTGreen or Lisp1DGreen
sporozoites, and 58 or 61 h later the infected cells were
isolated by ﬂuorescence-activated cell sorting and pro-
cessed for TEM. As shown in Fig. 5A, there was no dif-
ference between the development of WT and Lisp1
mutant parasites at 58 h. Indeed, the proportion of LS
containing morphologically mature merozoites was very
similar (20–30%). However, about 50% of the WT para-
sites were no longer surrounded by a visible PVM (Fig. 5B
and C) whereas the majority of Lisp1 mutant parasites
were packed within a membrane (Fig. 5D). At 61 h, we
were unable to observe WT LS containing merozoites
presumably because the breakdown of the PVM rendered
them too fragile to survive the sorting procedure. On the
contrary, mutant-infected cells were found and the major-
ity of these contained numerous merozoites inside a
visible PVM (Fig. 5E and F). The ultrastructure of these
merozoites appeared normal as assessed by the pres-
ence of a nucleus, rhoptries and a membrane coat (see
Fig. S6). These observations strongly support the role of
LISP1 in the PVM breakdown and merozoite egress from
the host cell.
SERA1 localization is modiﬁed in LISP1-defective LS
Several lines of evidence strongly suggest that SERA
cysteine proteases play an important role in the rupture of
the PVM (Sturm et al., 2009) so we assessed the distri-
bution of SERA-1 protein in LISP1-defective LS. HepG2
cells were infected with WTGreen or Lisp1DGreen sporo-
zoites and 48 h later the LS were stained with anti-SERA1
antibody. In WT LS the distribution of SERA gave a punc-
tuated signal located at the PVM whereas in the mutant
LS, the signal was more diffuse and possibly extended
beyond the PVM (Fig. 6 and Fig. S7). These data show
that in the absence of LISP1 the distribution of SERA1 is
modiﬁed.
Discussion
Egress from the host cell is a fundamental and recurrent
step of the Plasmodium life cycle. Evidence has now
accumulated indicating that the process occurs in two
distinct steps, with the rupture of the PVM preceding the
rupture of the host cell membrane. The molecular bases
of these processes, however, remain unknown.
Earlier work performed with erythrocytic forms of the
parasite (reviewed in Blackman, 2008) has suggested
that the breakdown of the PV and erythrocyte membranes
both depend on proteases but have distinct bases, since
treatment with E64, a cysteine protease inhibitor, selec-
tively blocks PVM rupture. Several lines of evidence
suggest that the cysteine proteases of the serine repeat
antigen (SERA) family (Debrabant et al., 1992), which
share a central papain-like domain, play a major role in
these processes. This gene family contains nine members
in P. falciparum and ﬁve in rodent-infecting species
(Arisue et al., 2007). In P. falciparum, SERA proteins are
expressed late during the schizogonic cycle (Hodder
et al., 2003; Le Roch et al., 2003; 2004) and accumulate
in the PV lumen (Knapp et al., 1989; 1991), and the para-
logues encoding SERA5 and SERA6 cannot be inacti-
vated (Miller et al., 2002a,b; McCoubrie et al., 2007). In
P. berghei, four of the ﬁve SERA-encoding genes are
Table 1. The ratio of merozoites released from HepG2 cells co-
infected with either WTGreen and WTRed or Lisp1DGreen and
WTRed sporozoites.
Experiment
No. WTGreen : WTRed Lisp1DGreen : WTRed
1 1.1:1 0.20:1
2 1.0:1 0.10:1
3 1.1:1 0.24:1
4 0.12:1
5 0.059:1
6 0.8:1 0.12:1
7 0.11:1
Ave 1.0:1 0.11:1
The average (Ave) ratio from seven independent experiments is
shown.
Fig. 4. Lisp1 mutant LS parasites are defective in the release of
merozoites. Graph showing the ratio of Green : Red hepatic
merozoites (hMZ) collected at 65 h from adherent HepG2 cells (left)
or the supernatant (right) co-infected with Lisp1DGreen and WTRed
or WTGreen and WTRed sporozoites and the ratios found in blood
stages (iRBC) after injection of these merozoites into mice. The
results obtained from the supernatant and adherent cells are
indicated. The average and standard deviation from four mice are
shown.
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SERA3 are released in the hepatocyte cytoplasm during
merozoite formation (Schmidt-Christensen et al., 2008).
Cysteine protease activity is known to be important for the
destruction of the LS-enclosing PVM, as well as in the
subsequent liberation of merosomes, since the two pro-
cesses are E64-sensitive (Sturm et al., 2006; Sturm and
Heussler, 2007). The available data thus indicate that the
SERA cysteine proteases play an important role in the
disruption of the PVM, although some additional, non-
cysteine protease activity is probably required for disrupt-
ing the host cell membrane. Gene targeting in P. berghei
also showed that SERA8, called egress cysteine protease
1 (ECP1), is important for sporozoite egress from extra-
cellular oocysts in the gut of the mosquito vector, inside
which parasites extensively multiply (Aly and Matus-
chewski, 2005).
We have characterized here a novel protein, LISP1,
which is produced by late LS and associates with their
enclosing PVM. Inactivation of Lisp1 in P. berghei
decreased 15-fold the LS capacity to generate a blood
infection in mice. In vitro, LISP1-deﬁcient hepatic mero-
Fig. 5. Lisp1 mutant merozoites remain within a PVM.
A. Histogram of the percentage of 58 h WTGreen and Lisp1DGreen unsegmented LS with no merozoites (US, lilac), and segmented LS
containing merozoites (S) with (yellow) or without (orange) a visible PVM.
B–F. Representative examples of hepatic schizonts 58 h (B–D) and 61 h (E and F) post infection. (B) WTGreen with PVM; (C) WTGreen
without PVM; (D) Lisp1D LS with PVM; (E and F) Lisp1D LS at 61 h containing many merozoites within a membrane boundary; scale bars are
2 mm. Insets show mature merozoites; scale bar is 500 nm and arrow heads indicate membrane.
1334 T. Ishino et al.
© 2009 The Authors
Journal compilation © 2009 Blackwell Publishing Ltd, Cellular Microbiology, 11, 1329–1339zoites were normally formed inside HepG2 cells, and dis-
played normal infectivity to erythrocytes. This indicates
that LISP1 does not play an important role in the function
of the PVM, either as a structural protein or as a
transporter. However, the PVM of defective LS was not
degraded and the merozoites remained trapped inside
hepatocytes. The timing of LISP1 production, its localiza-
tion and the phenotype of the defective mutant thus
suggest that LISP1 plays an important role in the rupture
of the LS-enclosing PVM. Nevertheless, since LISP1-
deﬁcient parasites give rise to a delayed blood infection in
mice, release of some merozoites can occur.
The molecular function of LISP1, annotated as a hypo-
thetical protein with a predicted signal peptide but no
recognizable functional domain, remains unknown. Being
located at the PVM, LISP1 might act as a membrane
receptor of the proteases and/or might be involved in
their activation/processing at the membrane. In erythro-
cytic merozoites, processing of the SERA proteases
depends on the subtilisin-like serine protease SUB1,
which is abundant in schizont stages and is discharged
from organelles named exonemes into the PV just prior
to egress (Yeoh et al., 2007). LISP1 might thus partici-
pate in the further processing of SERA proteases at the
PVM, activating their membrane-destabilizing capacity. In
the absence of LISP1, the SERA proteins might still be
secreted through the PVM without being activated,
hence the observed phenotype. Alternatively, LISP1
might be a target of the proteases, mediating membrane
dislocation itself upon hydrolysis or processing. Finally,
since LISP1 was not detected at the hepatocyte mem-
brane, it seems unlikely that it is also directly involved in
merosome formation and hepatocyte/merosome mem-
brane disruption.
Most members of the Apicomplexa phylum, to which
Plasmodium belongs, invade host cells and multiply within
the conﬁnes of a PVM that they must eventually breach
(Blackman, 2008). In spite of this conserved behaviour, it
is striking that all Plasmodium products identiﬁed so far as
being involved in the function/structure of the PVM, such
as the ETRAMPs, or in its disruption, such as the SERA
proteases, are speciﬁc to the genus. Moreover, these
products come in stage-speciﬁc paralogues adapted to
the particular host cell harbouring the PV. LISP1, which
appears to be speciﬁc to the Plasmodium genus, is impor-
tant for parasite egress from hepatocytes but dispensable
for egress from erythrocytes. LISP1 thus adds to the
notion of exquisitely speciﬁc mechanisms involved in the
lysis of the PVM by Apicomplexa parasites.
Experimental procedures
P. berghei strains and the infection of mice, rats and
mosquitoes
ANKAGreen is ANKA 507m6cL1 which expresses GFP from the
eef1a promoter (Janse et al., 2006a) and was obtained from
MR4 (MRA-867), deposited by C.J. Janse and A.P. Waters;
ANKARed (ANKA L733), expressing RFP from eef1a promoter,
is described in Sturm et al. (2009). Infection of mice, Anopheles
stephensi mosquitoes and isolation of salivary gland sporozoites
were performed as previously described (Thiberge et al., 2007).
All studies on animals followed the guidelines on the ethical use
of animals from the European Communities Council Directive of
24 November 1986 (86/609/EEC).
Real-time reverse transcription polymerase chain
reaction (RT-PCR)
Two independent total RNA preparations were made from mixed
infected blood stages, salivary gland sporozoites at day 21 post
infection and HepG2 cells 5, 17, 40 and 50 h post infection. PCR
conditions were one cycle at 95°C for 10 min, 40 cycles at 95°C
for 15 s, 55°C for 15 s and 60°C for 45 s. Lisp1 gene expression
was normalized by the hsp70 (PB001074.01.0) gene expression
in each sample. Analysis was performed using the DCt method
(User Bulletin 2, Applied Biosystems) using the blood stages as
reference.
Primers used: lisp1F5 ′-GCCAAATGCTAAACCTAATG-3′;
lisp1R5 ′-TGGGTTTGTATTGTATGCAC-3′; hsp70F5 ′-TGCAGC
AGATAATCAAACTC-3′; hsp70R: 5′-ACTTCAATTTGTGGAACA
CC-3′.
Rabbit anti-LISP1 antibody preparation
LISP1 amino acids 1392–1437 were fused to glutathione
S-transferase (GST) using the pGEX 6P-1 system (Amersham
Bioscience, Uppsala, Sweden). The protein was puriﬁed on a
GST column and used to immunize rabbits. Speciﬁc antibodies
were affinity puriﬁed on an N-hydroxysuccinimide-activated
column (Amersham Bioscience) coupled with recombinant
protein. The antibody titre was 1.07 mg ml-1.
Fig. 6. Localization of SERA1 is modiﬁed in Lisp1 mutant LS
parasites. HepG2 cells were infected with wild type (WT, top) or
Lisp1DGreen sporozoites (Lisp1D, bottom) and 48 h later the LS
were stained an anti-SERA1 antibody (red) and nuclei stained with
DAPI (blue).
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Puriﬁed parasites were ﬁxed in acetone for 2 min and the
samples incubated with rabbit anti-LISP1 antibodies then FITC-
conjugated secondary antibody (Zymed, South San Francisco,
CA, USA). For nuclear staining, 0.02 mgm l
-1 4′, 6-diamidino-2-
phenylindole (DAPI) was added to the secondary antibody
solution.
For IFA of LS in infected HepG2 cells, ﬁxation was either 4%
paraformaldehyde (PFA) + 0.1% triton or acetone, and incubation
was with anti-LISP1 antibodies and Alexa 647-conjugated sec-
ondary antibody. PFA (4%) ﬁxation and 0.1% triton permeabiliza-
tion were used with the anti-UIS4 antibody. Methanol ﬁxation was
used with anti-EXPI and anti-SERA1 antibodies.
Targeted disruption of lisp1 and genotypic analysis
Construction of the lisp1I targeting vector. Two fragments of 853
and 801 bp were ampliﬁed from genomic DNA with primers:
5′-GGGGAGCTCGTCTATTTTTGATACGATATGTGCACATGC-3′
and 5′-GGGGGATCCCTTGAAGGCGATTAACTATATTGTCGC-
3′;5 ′-GGGCTCGAGCGAATCAGTGTCGCTTGATATTTTG-3′
and 5′-GGGGGTACCCTGGGTTTGTATTGTATGCACCTAAGG-
3′ and cloned either side of the selectable marker gene in pBlue-
script (Stratagene, La Jolla, CA, USA). For Southern analysis
ANKA genomic DNA was digested with SphI and hybridized
with a probe made from ampliﬁcation with primers: 5′-GGG
GAGCTCGTCTATTTTTGATACGATATGTGCACATGC-3′ and
5′-GGGGGATCCCTTGAAGGCGATTAACTATATTGTCGC-3′.
Construction of the Lisp1D targeting vector. Two fragments of
630 and 600 bp were ampliﬁed from genomic DNA with primers
5′-CGATGCGGGCCCGAGAATACAACTTACTAGGAAATGCAC-
3′ and 5′-AGCTGGCGCGCCCTTGCATCTTCAGACATGTTA
TTTTCGA-3′;5 ′-CCAGTGAGTGCGGCCGCGGCTAAAGCTCG
ATGTCGTATTCAAGAA-3′ and 5′-AGCTGGCGCGCCCTGGG
AATTTTTCAATTTCTTCCATTTG-3′. These primers were tailed
with restriction sites for ApaI, SmaI, NotI and AscI respectively.
The fragments were cloned in the vector pBC-hDHFR vector (B.
Boisson, unpublished). This vector is pBC SK (+) (Stratagene),
modiﬁed to introduce an AscI restriction site, and contains a
human dihydrofolate reductase (hDHFR) selection cassette with
the 5′ untranslated region of the eef1a gene and the 3′ untrans-
lated region of the DHFR-TS gene cloned between SmaI and
NotI of pBC SK (+). Transfection and selection of recombinant
parasites was performed as previously described (Janse et al.,
2006b). Southern analysis was performed on SphI-restricted
genomic DNA hybridized with the probe indicated on Fig. S2.
Evaluation of sporozoite infectivity in vivo
Sporozoites collected from mosquito salivary glands were
injected intravenously into 3-week-old female Wistar rats (Japan
SLC, Hamamatsu, Japan) (n = 5) or 4-week-old C57BL/6 mice
(Janvier, France). Parasitaemias were checked at indicated time
points by Geimsa-stained blood smear.
LS development assay in vivo
A total of 300 000 Lisp1I or WT sporozoites were injected into
3-week-old Wistar rats and 48 h later, the livers were perfused
with phosphate-buffered saline (PBS) then 4% PFA. After inclu-
sion in 20% sucrose, 20 mm frozen sections were prepared on a
Leica cryostat. The sections were stained with anti-CS antiserum
and the number of LS in six sections from each rat was counted.
A total of 1619 Lisp1I, 1877 WT LS were counted.
LS development in HepG2 cells
HepG2 cells were grown in DMEM + Glutamax-1 media (Gibco)
supplemented with 10% FCS (PAA laboratories GmbH) at 37°C
in the presence of 5% CO2. The day before infection 4–5.0 ¥ 10
4
were plated per well in eight-well chamber slides (Nalge Nunc
International, Rochester, NY, USA) and 24 h later WT and/or
mutant sporozoites (5.0 ¥ 10
4) were added. The medium was
changed daily. The LS were detected by immunoﬂuorescence
staining as described above.
Real-time imaging of LS development in HepG2 cells
HepG2 cells were co-infected with WTRed and Lisp1DGreen
sporozoites. The development of 27 WT and 28 mutant LS was
followed from 24 to 48 h post infection by acquisition of images at
60 min intervals with a PerkinElmer spinning disc confocal micro-
scope. The area was calculated using ImageJ software.
Detection of LISP1 by immunoblot
HepG2 cells were infected with WTGreen or Lisp1DGreen sporo-
zoites as described above. After 48 h the cells from each well
were lysed in Novex
® Tris-Glycine sodium dodecyl sulfate (SDS)
sample buffer (Invitrogen) and immediately stored at -80°C. Prior
to loading on a 4–15% gradient acrylamide gel (Bio-Rad), b
mercaptoethanol was added (0.7 M ﬁnal) and the samples were
heated for 5 min at 95°C. Molecular weight markers were Preci-
sion Plus Protein (Bio-Rad). After electrophoresis the proteins
were transferred to a Hybond-ECL nitrocellulose membrane
(Amersham Biosciences). The membrane was ﬁrst incubated
with a 1:2000 dilution of the anti-LISP1 antibody then with a
1:10 000 dilution of a chicken anti-rabbit IgG horseradish peroxi-
dase (HRP)-conjugated antibody (Santa Cruz). The presence of
antibodies was revealed with the SuperSignal
® West Femto kit
(Thermo Scientiﬁc). The membrane was then incubated with a
1:10 000 dilution of HRP-conjugated rabbit polyclonal anti-
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) (Santa
Cruz) and the same kit used to reveal the presence of antibodies.
The signals were scanned using Quantity One software (Bio-
Rad) and quantiﬁed with NanoDrop ND-1000 software (Thermo
Fischer Scientiﬁque).
Estimation of number of hepatic merozoites
HepG2 cells were co-infected with equal numbers of either
WTRed and WTGreen or WTRed and Lisp1DGreen sporozoites.
Sixty-ﬁve hours later the supernatants were taken, centrifuged for
3 min at 12 000 r.p.m. and the pellet re-suspended in PBS. Cells
were scraped from the wells and mechanically disrupted by
passing through a Omnican® 30G insulin needle. The samples
were placed on Ibidi slides and observed with a Zeiss Axio
observer Z1 microscope.
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WTGreen or Lisp1DGreen sporozoites were added to HepG2
cells and 58 or 61 h later cells were collected, ﬁxed with 0.4%
PFA and GFP-positive cells enriched by sorting on a FACSAria
(BD Biosciences). Sorted cells were ﬁxed with 2.5% glutaralde-
hyde in 0.1 M cacodylate buffer at 4°C for 24 h. Then, cell pellets
were embedded in agarose type IV (Sigma, Chemical, Saint
Louis, USA). After several washes in 0.1 M cacodylate buffer,
samples were post-ﬁxed for 1 h with 1% osmium tetroxide
(Merck, Darmstadt, Germany) in the same buffer. After dehydra-
tion in a graded ethanol series, the samples were embedded in
Epon resin and polymerized. Contrasted ultra-thin sections
(60 nm) were observed in a JEM 1010 Transmission Elecron
Microscope (Jeol, Tokyo, Japan). A total of 103 Lisp1DGreen and
62 WT LS were observed at 58 h.
Statistical analysis
The data presented in Figs 1A, 2E and 3A were analysed by a
Kruskal–Wallis rank sum test. The data presented in Fig. 4 were
analysed by a Mann–Whitney test.
Data deposition
Sequences from the EST libraries were deposited in the DDBJ
website 2007. The LISP1 sequence reported in this article has
been deposited in the GenBank database (Accession No.
AB231328).
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Supporting information
Additional Supporting Information may be found in the online
version of this article:
Fig. S1. Histogram representation of real-time RT-PCR analysis
of lisp1 relative gene expression in rat livers 24, 48 and 60 h post
infection. Total liver RNA was isolated 24, 48 and 60 h post
infection with RNAgents Total RNA Isolation System (Promega,
Madison, WI, USA) and cDNAs made. Lisp1 was ampliﬁed with
primers 5′-GCCCCCTGGCGATCTTAATTT-3′ and 5′-TAAACG
TTTCAGGGGGCGAT-3′. The expression was normalized to
rat glyceraldehyde-3-phosphate dehydrogenase, ampliﬁed with
primers 5′-TGATTCTACCCACGGCAAGTT-3′ and 5′-TGATGGG
TTTCCCATTGATGA-3′. Error bars are standard deviation.
Fig. S2. Gene inactivation of lisp1.
A. Double-crossing-over strategy used to generate Lisp1I mutant
parasites. Genomic DNA of ANKA (WT) and two clones of Lisp1I
digested with SphI and hybridized with a 5′ probe indicated by a
thick black line.
B. Double-crossing-over strategy used to generate Lisp1D
clones in NK65 and WTGreen. Genomic DNA was digested with
SphI and hybridized with a 5′ probe indicated by a thick black line.
Fig. S3. Infectivity of Lisp1DGreen sporozoites compared with
WTGreen (wild type). A total of 25 000 salivary gland sporozoites
were injected intravenously into C57Bl/6 mice and blood-stage
parasitaemias checked daily. Bars indicate standard errors.
Fig. S4. The size of lisp1-defective LS is normal.
A. Histogram representation of the size of LS in HepG2 cells
co-infected with WTRed (Wild type, white box) and Lisp1DGreen
(black box) sporozoites. The LS parasites were detected by their
ﬂuorescence and imaged by spinning disk confocal microscopy
and the relative area calculated with ImageJ software.
B. Sample of sorted HepG2 cells 58 h post infection with
WTGreen (top) or Lisp1DGreen sporozoites used for TEM.
Fig. S5. Lisp1I merozoites express AMA1. Merozoites collected
from the supernatant of HepG2 cells infected with ANKA and
Lisp1I sporozoites were incubated with an anti-AMA1 antibody
and Alexa 546-conjugated secondary antibody.
Fig. S6. Transmission electron micrographs of WT and mutant
LS 59 h post infection.
A. WT LS with numerous merozoites in the host cytoplasm and
absence of PVM. The aspect of the nucleus indicates that the cell
is dying.
B. Lisp1DGreen LS with many merozoites and a visible PVM.
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zoites appear normal at the ultrastructural level with the presence
of a nucleus, rhoptry and coated membrane.
Fig. S7. Immunoﬂuorescence analysis of LS 48 h post infection
of HepG2 cells with WT sporozoites. Samples were incubated
with an anti-LISP1 antibody and an anti-SERA1 antibody
followed by Alexa-conjugated secondary antibodies. LISP1
labelling in green, left; SERA1 labelling in red, centre; merged
image, right.
Please note: Wiley-Blackwell are not responsible for the content
or functionality of any supporting materials supplied by the
authors. Any queries (other than missing material) should be
directed to the corresponding author for the article.
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